This story originally ran on April 22.

Gentel Biosciences and Protein Biotechnologies have forged a collaboration to market and sell reagents and reverse-phase protein arrays.

The deal, reached last week, covers Protein Biotechnologies' SomaPlex arrays and Gentel's APiX View Detection Kits, which were launched this week, a company official told ProteoMonitor.

The kits allow for the "ultra-sensitive" chromogenic detection of protein microarrays, Gentel said in a statement.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.